Literature DB >> 266733

L-3,4-dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation.

L C Tang, G C Cotzias.   

Abstract

The manner in which dyskinesia and intermittency of neurological control had emerged late in the therapy of Parkinsonism with L-3,4-dihydroxyphenylalanine (levodopa) had suggested to us that this drug can imprint on the brain a chemical memory of its passage. The majority of authors ascribed these events to denervation hypersensitivity caused by the nigral and other lesions of the disease. By feeding levodopa to mice, however, we induced a state that simulated denervations hypersensitivity, including hyperreaction to single injections of levodopa and increased dopamine-stimulated adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] activity in homogenates of caudate nuclei. These phenomena were not caused by actual denervation, because the hypersensitivity declined and disappeared some weeks after the dietary levodopa was stopped.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266733      PMCID: PMC431088          DOI: 10.1073/pnas.74.5.2126

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Dopamine-sensitive adenylate cyclase: location in substantia nigra.

Authors:  K Gale; A Guidotti; E Costa
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

2.  Quantitative correlation of dopamine-dependent adenylate cyclase with responses to levodopa in various mice.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Dopaminergic denervation supersensitivity and dopamine stimulated adenyl cyclase activity.

Authors:  P F Von Voigtlander; S J Boukma; G A Johnson
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

5.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  The pharmacology of tardive dyskinesias.

Authors:  H L Klawans
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

7.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

8.  Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.

Authors:  A S Horn; A C Cuello; R J Miller
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

Review 9.  The clinical physiology of side effects in long-term L-DOPA therapy.

Authors:  A Barbeau
Journal:  Adv Neurol       Date:  1974

10.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  4 in total

1.  Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.

Authors:  R M Stewart; A Campbell; G Sperk; R J Baldessarini
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

2.  Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 3.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

4.  [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.

Authors:  Y Clement-Cormier; C E Smith
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.